Patents
Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848)
04/2005
04/05/2005US6875764 Urea and thiourea compounds useful for treatment of coccidiosis
04/05/2005US6875760 Glucagon antagonists/inverse agonists
03/2005
03/31/2005WO2005028445A2 Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain
03/31/2005WO2005007732A3 Polyurea polymers from secondary polyether polyamines
03/31/2005US20050070485 Phenylalanine derivatives
03/31/2005CA2539165A1 Cinnamoyl compound and use of the same
03/31/2005CA2538960A1 Cinnamoyl compound and use of the same
03/31/2005CA2538454A1 Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain
03/30/2005EP1517680A1 Benzoic acid derivatives as modulators of ppar alpha and gamma
03/30/2005EP1010690B1 Biarylalkylenecarbamic acid derivatives and bacteriocides for agricultural and horticultural use
03/30/2005EP0976724B1 Process for the synthesis of urea and equipment therefor
03/30/2005CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
03/29/2005US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents
03/29/2005US6872748 Antiinflammatory agents; central nervous system pain; capsaicin
03/29/2005CA2244190C Method of producing press-moulding materials with polyisocyanate binders and using latent, heat-activable catalysts
03/24/2005WO2004064730A3 Compounds, compositions and methods
03/24/2005WO2004046162A8 Non-steroidal fxr agonists
03/24/2005US20050065147 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity
03/24/2005CA2551022A1 Polyethyleneglycol-modified lipid compounds and uses thereof
03/22/2005US6870021 Mixtures of condensation polymers comprising organonitrogen or organosulfur polymers and curing agents, having preferential binding, used for analysis, separation and resolution of racemic mixtures
03/22/2005CA2225250C Bicyclic amino derivatives and pgd2 antagonist containing the same
03/17/2005US20050059729 Substituted cyclic compounds
03/17/2005US20050059611 such as 3-{4-[1-(4-Cyclohex-1-enylphenyl)-3-(3,5-dichlorophenyl)ureidomethyl]benzoylamino}-2,2-difluoropropionic acid), used for treatment and/or prevention of hyperglycemia, diabetes, lipid metabolism disorders and obesity
03/16/2005EP1514867A2 Substituted phenyl derivatives, their preparation and use
03/16/2005EP1513959A2 Antiviral inhibitions of capsid proteins
03/16/2005EP1513800A1 N-benzoylureidocinnamate derivatives, method for production and use thereof
03/16/2005EP1115758B1 Polymerization of olefins
03/16/2005EP1049664B1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
03/16/2005EP0874625B1 Indane derivatives for antipsychotic compositions
03/16/2005CN1193019C Method and reagents for N-alkylating ureides
03/15/2005US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency
03/10/2005WO2005021499A1 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity
03/10/2005WO2005020899A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity
03/10/2005US20050054819 Such as 1-benzylcyclobutyl (1S)-1-(oxo{[(1R)-1-phenylethyl]amino}acetyl)pentylcarbamate for treatment of osteoporosis
03/10/2005US20050054626 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
03/10/2005US20050054582 Para-amino benzoic acids as integrin antagonists
03/10/2005CA2533175A1 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases
03/09/2005EP1511710A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer s disease, type 2 diabetes, and parkinson s disease
03/09/2005EP1511482A1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
03/09/2005CN1590375A TNF-alpha prodn. inhibitors
03/09/2005CN1590374A TNF-alpha prodn. inhibitors
03/09/2005CN1192015C Cell adhesion inhibitors
03/08/2005US6864380 Antiinflammatory agents; asthma; antiallergens; autoimmune diseases; antiarthritic agents
03/03/2005WO2005019174A1 Acetylene derivatives as inhibitors of histone deacetylase
03/03/2005WO2005000803A3 Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst
03/03/2005CA2535350A1 Acetylene derivatives as inhibitors of histone deacetylase
03/02/2005EP1509509A1 Glucagon antagonists/inverse agonists
03/02/2005EP1509497A1 Calcium receptor modulating arylalkylamines
03/02/2005EP1042279B1 Substituted beta-alanines
02/2005
02/24/2005US20050043534 Modulators of ceramidase and methods of used based thereon
02/24/2005US20050043371 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
02/24/2005DE10302452B4 Carbonylamino-substituierte Acyl-phenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung Carbonylamino-substituted acyl-phenyl-urea derivatives, processes for their preparation and their use
02/23/2005EP1508565A1 Process for the preparation of optically active aminoalcohols
02/23/2005CN1585633A Phenethanolamine derivatives for treatment of respiratory diseases
02/23/2005CN1583716A Preparing method for inactive nitric acid powder
02/23/2005CN1190414C Combined prep. of ammonia and urea
02/22/2005US6858651 2,3-oxidosqualene-lanosterol cyclase inhibitors
02/22/2005CA2129039C Tri-substituted phenyl derivatives as phosphodiesterase inhibitors
02/17/2005WO2005015158A2 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
02/17/2005US20050038248 Chemotherapeutic agents
02/17/2005US20050038105 non-peptide molecules, comprising side chains of amino acids, capable of adopting a helicoidal structure independent of the primary structure of the molecules; mimics active natural helices
02/17/2005US20050038100 Eating disorders; anticholesterol agents; hypotensive agents; sleep disorders; hyperphagia
02/17/2005US20050038002 Bactericides; antitumor agents; moderators of gene expression; viricides; parasiticides; malaria therapy
02/17/2005CA2535045A1 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
02/16/2005EP1506168A2 Gelling agents
02/16/2005EP1506167A1 Hydroxy tetrahydro-naphthalenylurea derivatives
02/16/2005EP1506166A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
02/16/2005EP1244617B1 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
02/16/2005CN1580042A Substituted benzoyl urea insect growth regulator synthesizing method
02/16/2005CN1189452C Production process of phenyl carbamide and/or diphenyl carbamide
02/15/2005US6855843 Antihistamines; rheumatic diseases; antidiabetic agents; inflammatory bowel disorders
02/15/2005US6855706 Phenylalanine derivatives
02/10/2005WO2005012231A1 Aminocarbonyl naphthol derivative, cyanonaphthol derivative, and method for producing them
02/10/2005WO2004077511A3 (meth)acrylic and (meth)acrylamide monomers, polymerizable compositions, and polymers obtained
02/10/2005US20050032831 Histone deacetylase inhibitors and methods of use thereof
02/10/2005US20050032789 Novel compounds useful in pain management
02/09/2005EP1503981A2 Substituted tetracycline compounds
02/09/2005CN1578663A Inhibitors of histone deacetylase
02/09/2005CN1188394C N-substituted-N'-substituted urea derivative and medicinal compositions containing the same
02/09/2005CN1188388C Aminobenzophenones as inhibitors of interleukin and TNF
02/08/2005CA2096525C Retroviral protease inhibitors
02/08/2005CA2096409C Retroviral protease inhibitors
02/08/2005CA2096408C Retroviral protease inhibitors
02/03/2005WO2005009944A1 Prodrugs of 9-aminomethyl tetracycline compounds
02/03/2005WO2005009943A2 Substituted tetracycline compounds
02/03/2005WO2005009940A1 Novel aminobenzophenone compounds
02/03/2005US20050027120 Method for the synthesis of amides and related products from esters or ester-like compounds
02/03/2005US20050026875 Treating bacterial, viral, or fungal infections, cancer, a lung injury, an eye disorder, neurological disorder or stroke
02/03/2005US20050026844 Inhibitors for the soluble epoxide hydrolase
02/03/2005CA2532898A1 Stable liquid biuret modified and biuret allophanate modified toluene diisocyanates, prepolymers thereof, and processes for their preparation
02/03/2005CA2531728A1 Substituted tetracycline compounds
02/03/2005CA2530302A1 Novel aminobenzophenone compounds
02/02/2005EP1501815A1 Substituted phenylacetamides and their use as glucokinase activators
02/02/2005EP1501800A1 Bombesin antagonists
02/02/2005EP1501790A2 Novel sodium channel blockers
02/02/2005EP1501789A1 Amidinylphenyl compounds and their use as fungicides
02/01/2005US6849760 Organic acid and inorganic acid salts of chiral amine alcohol intermediates.
02/01/2005US6849742 Binaphthol derivative and process for producing the same
02/01/2005US6849617 Administering Tissue factor pathway inhibitors for prophylaxis of thrombosis and cardiovascular disorders; anticoagulants
01/2005
01/27/2005WO2005007732A2 Polyurea polymers from secondary polyether polyamines
1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 99